HealthcareJul 16, 2026

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Company Profile Analysis

Book Demo Subscribe Now

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. - Healthcare showcase

Year Founded & Workforce

1968-12-31

1,800 Employees

Industry

Healthcare

Services

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Overview

Company Headquarters: Nanjing, China

Founded: 1969

Workforce: ~ 1,800

Company Working: Chia Tai Tianqing Pharmaceutical Group Co. produces and manufactures pharmaceutical products. The company sells drugs for diseases like diabetes, liver disease, cancer, cardiovascular disease, anti-infective, digestion problems, and respiratory problems. Chia Tai Tianqing Pharmaceutical Group distributes its products domestically and internationally. With GMP-based clearance from the US FDA and EU Health Authority, as well as specialized and diversified products in development, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), one of the top 30 pharmaceutical companies in China, anticipates being more active in foreign business. In addition, it operates s as a subsidiary of Sino Biopharmaceutical Limited. It has 3 manufacturing plants focusing on FDF and API production, 2 R&D centers, 1 overseas branch (CTTQ EU) in Barcelona, Spain, 1 business development office in San Diego, USA, and 4 joint labs (in Shanghai and Chengdu).

Strategy

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is committed to innovation and study of products that have production or technological barriers in order to elevate people's quality of life and progress human health. Moreover, the company's growth strategy is built on introducing superior items based on scientific advancements. In addition, the company is planning to usher in a digital revolution by using digital technologies, advanced analytics, and artificial intelligence to help boost innovation and efficiency.

Company Snapshot

1,800

Employees

1968-12-31

Founded

Nanjing, China

Headquarters

Key Developments

Date	Approach	Development
August 2018	Product Launch	Chia Tai Tianqing Pharmaceutical Group Co., Ltd. launched anlotinib hydrochloride capsules. Anlotinib Hydrochloride Capsules (brand name: "FOCUS V"). Anlotinib Hydrochloride Capsules Combined with TQB2450 Injection is used to treat patients with Esophageal Squamous Cell Carcinoma.

Product Offering

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Esophageal squamous cell carcinoma

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Chia Tai Tianqing Pharmaceutical Group Co., Ltd. as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Company Headquarters: Nanjing, China Founded: 1969 Workforce: ~ 1,800 Company Working: Chia Tai Tianqing Pharmaceutical Group Co. produces and manufactures pharmaceutical products. The company sells drugs for diseases like diabetes, liver disease, cancer, cardiovascular disease, anti-infective, digestion problems, and respiratory problems. Chia Tai Tianqing Pharmaceutical Group distributes its products domestically and internationally. With GMP-based clearance from the US FDA and EU Health Authority, as well as specialized and diversified products in development, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), one of the top 30 pharmaceutical companies in China, anticipates being more active in foreign business. In addition, it operates s as a subsidiary of Sino Biopharmaceutical Limited. It has 3 manufacturing plants focusing on FDF and API production, 2 R&D centers, 1 overseas branch (CTTQ EU) in Barcelona, Spain, 1 business development office in San Diego, USA, and 4 joint labs (in Shanghai and Chengdu).

Starting from

$4,950